Synektik

Synektik EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Synektik (SNT.WA) as of Oct 31, 2026 is 41.77. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 55.28 — a change of -24.44% (lower).

EV/FCF

41.77

YoY

-24.44%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Synektik is 2025 41.77 . EV/FCF (Enterprise Value to Free Cash Flow) of Synektik was 2024 55.28 . It decreases by -24.44% lower compared to the previous year.

The Synektik EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
892.52 PLN
Jan 1, 2019
315.79 PLN
Jan 1, 2020
288.53 PLN
Jan 1, 2021
138.57 PLN
Jan 1, 2022
-156.00 PLN
Jan 1, 2023
28.87 PLN
Jan 1, 2024
55.28 PLN
Jan 1, 2025
41.77 PLN
The Synektik EV/FCF history
YEAREV/FCFYoY
41.77-24.44%
55.28+91.50%
28.87-118.51%
-156.00-212.58%
138.57-51.97%
288.53-8.63%
315.79-64.62%
892.52+179.45%
319.38-289.84%
-168.24-67.59%
-519.11-35.05%
-799.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

EV/FCF (Enterprise Value to Free Cash Flow) of Synektik is 41.77 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Synektik changed from 55.28 to 41.77, representing a -24.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Synektik since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Synektik with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Synektik

All Key Metrics — Synektik